Swiss pharma Roche has today officially launched a new institute that will focus on the use of human model systems – in vitro replicas of human tissues and organs – for dr
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh